Posted on 30/11/2009 in Medical Company Financials Corin Group has published its interim financial results for the period spanning July 1st to 17th November 2009.
The firm's sales in Europe were marginally ahead of the comparative period, representing a slight improvement on the first half, the company revealed.
Although sales margins were negatively affected by the average US dollar to pound exchange rate during the second half of 2009, this was partially offset by the weakness of sterling against the Australian dollar, the firm stated.
During this timeframe, the company's new Trinity acetabular system was approved by the UK regulator and the first evaluation surgery using the cup was carried out on November 12th.
Chief executive officer of the Corin Group Peter Huntley stated: "We are pleased with the progress of our new product development programme and the start of evaluation surgeries for the Trinity system is a significant milestone in this regard."
The company, which was established in 1985, develops, manufactures and distributes a range of reconstructive orthopaedic devices.
Other news stories from 30/11/2009
Read more in the Zenopa News Archive
How this news is generated
|
